반응식
[CH2:1]([C:3]1(O)[C:11]2[C:6](=[CH:7][C:8]([F:12])=[CH:9][CH:10]=2)[CH2:5][CH2:4]1)[CH3:2].[CH3:14][O:15][C:16]1[CH:17]=[CH:18][CH:19]=[C:20]2[C:24]=1[NH:23][CH:22]=[CH:21]2>>[CH2:1]([C:3]1([C:21]2[C:20]3[C:24](=[C:16]([O:15][CH3:14])[CH:17]=[CH:18][CH:19]=3)[NH:23][CH:22]=2)[C:11]2[C:6](=[CH:7][C:8]([F:12])=[CH:9][CH:10]=2)[CH2:5][CH2:4]1)[CH3:2]참가 물질
3
실험 절차
Utilizing 1-ethyl-5-fluoro-indan-1-ol and 7-methoxyindole, the title compound is prepared as in example 1. 123 mg (59%). LC-MS m/z 310.2 (M++1).
출처 및 근거
- ORD 기록
- ord-5204ade0db7a47d9aede56c426b03f2f
- 출처 데이터셋
- uspto-grants-2010_06
- 특허 번호
- US07728150B2
연결된 노트
불러오는 중…